Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $100.3800 (-2.39%) ($95.0800 - $100.4800) on Fri. Feb. 24, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.72% (three month average) | RSI | 22 | Latest Price | $100.3800(-2.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1% a day on average for past five trading days. | Weekly Trend | LGND declines -2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(56%) XBI(56%) IWC(53%) IWM(52%) | Factors Impacting LGND price | LGND will decline at least -0.86% in a week (0% probabilities). TLT(-15%) VIXM(-14%) UUP(-8%) GDXJ(-6%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.86% (StdDev 1.72%) | Hourly BBV | 0 () | Intraday Trend | 2.4% | | | |
|
Resistance Level | $105.3 | 5 Day Moving Average | $103.5(-3.01%) | 10 Day Moving Average | $104.71(-4.14%) | 20 Day Moving Average | $105.3(-4.67%) | To recent high | -8.2% | To recent low | 0% | Market Cap | $1.613b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |